Venetoclax-Rituximab Outshines Bendamustine Ri... - CLL Support
Venetoclax-Rituximab Outshines Bendamustine Rituximab for Relapsed/Refractory CLL
You need to be a member of this community to see this post.
Read more about...
Featured Content
Jump to replies10 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Role of RITUXIMAB in CLL treatment in combination with Venetoclax
Hello to all fellows in the CLL journey!
Has anyone found a clear answer as to what exactly is the...
Scottish Medicines Consortium approves Venetoclax + Rituximab Treatment for relapsed/refractory CLL
Venetoclax has been approved by the Scottish Medicines Consortium (SMC) for treating adults with...
Ibrutinib V Venetoclax + Rituximab
I had FCR treatment for CLL about 6 years ago but a number of lymph nodes now getting lumpy. I am...
Comparative analysis of targeted novel therapies (ibrutinib vs. venetoclax) in relapsed, refractory CLL (Feb 2020)
"To date, no prospective trials have directly compared ibrutinib with venetoclax as NA1 in R/R CLL....
Venetoclax(ABT-199)/rituximab achieved an Overall Rate of Response of 88%
ASH2014 - Clinical Care Options (free to join) capsule update on...
Venetoclax (ABT-199)Plus...